FibroGen(FRA) 1FG

Market CapN/A

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

N/A

FibroGen Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$3.95

Net Income (TTM)

-$26.44

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

1FG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About FibroGen

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Thane Wettig, MBA

Website

www.kyntrabio.com

1FG Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

N/A

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Payout Ratio

N/A

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

FibroGen Performance Analysis

FibroGen annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 133,908,125	-32.7%
2023	2023-12-31	USD 43,291,393	-67.7%
2024	2024-12-31	USD 27,383,982	-36.7%
2025	2025-12-31	USD 5,706,296	-79.2%

FibroGen annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -74.64	12.4%
2023	2023-12-31	USD -67.55	-9.5%
2024	2024-12-31	USD -10.99	-83.7%
2025	2025-12-31	USD 40.19	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

-$1.27

-1.1%

Gross Profit

-$1.27

-1.4%

Gross Margin

-10.03%

-0.1%

Market Cap

N/A

Market Cap/Employee

$0.73

N/A

Employees

N/A

Net Income

$10.30

-0.9%

EBITDA

-$15.10

+1.5%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$44.30

-55.4%

Total Debt

$0.00

+0.0%

Accounts Receivable

$0.30

+2.6%

Inventory

$2.96

+0.9%

Long Term Debt

$0.00

+0.0%

Short Term Debt

$0.00

+0.0%

Return on Assets

-22.02%

+0.9%

Return on Invested Capital

555.49%

N/A

Free Cash Flow

-$3.51

-0.3%

Operating Cash Flow

-$3.51

-0.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About 1FG

What is the current price of FibroGen?

FibroGen is trading at N/A per share.

What is the 52-week range for FibroGen?

Over the past 52 weeks, FibroGen has traded between N/A and N/A.

How much debt does FibroGen have?

As of the most recent reporting period, FibroGen reported total debt of $0.00.

How much cash does FibroGen have on hand?

FibroGen reported $44.30M in cash and cash equivalents in its most recent financial results.

What is FibroGen’s dividend yield?

FibroGen does not currently have a dividend yield.

FibroGen(FRA) 1FG

FibroGen Financials at a Glance

1FG News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About FibroGen

1FG Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

FibroGen Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About 1FG

What is the current price of FibroGen?

What is the 52-week range for FibroGen?

How much debt does FibroGen have?

How much cash does FibroGen have on hand?

What is FibroGen’s dividend yield?

Premium Investing Services